000 | 01820 a2200505 4500 | ||
---|---|---|---|
005 | 20250516022932.0 | ||
264 | 0 | _c20110513 | |
008 | 201105s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1093/cid/ciq249 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDouglas, Nicholas M | |
245 | 0 | 0 |
_aPlasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cMar 2011 |
||
300 |
_a612-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntimalarials _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
650 | 0 | 4 |
_aMalaria, Vivax _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMyanmar |
650 | 0 | 4 |
_aPlasmodium falciparum _xisolation & purification |
650 | 0 | 4 |
_aPlasmodium vivax _xisolation & purification |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aNosten, François | |
700 | 1 | _aAshley, Elizabeth A | |
700 | 1 | _aPhaiphun, Lucy | |
700 | 1 | _avan Vugt, Michèle | |
700 | 1 | _aSinghasivanon, Pratap | |
700 | 1 | _aWhite, Nicholas J | |
700 | 1 | _aPrice, Ric N | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 52 _gno. 5 _gp. 612-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/ciq249 _zAvailable from publisher's website |
999 |
_c20571275 _d20571275 |